News

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...
Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...